Industry

Life Sciences Tools & Services

Suppliers of instruments, reagents and contract research for biotech and pharma R&D. Stable demand from growing research budgets; switching costs and proprietary tech provide defensibility.

Total Companies
238
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
Thermo Fisher Scientific Inc
NYSE:TMO
Loading...
14% Overvalued
52 / 100
45 / 100
$236.6B
Danaher Corp
NYSE:DHR
Loading...
16% Overvalued
50 / 100
65 / 100
$168.5B
Lonza Group AG
SIX:LONN
Loading...
23% Undervalued
50 / 100
53 / 100
$47.9B
WuXi AppTec Co Ltd
SSE:603259
Loading...
17% Undervalued
62 / 100
84 / 100
$42.8B
IQVIA Holdings Inc
NYSE:IQV
Loading...
16% Undervalued
53 / 100
30 / 100
$40.8B
Agilent Technologies Inc
NYSE:A
Loading...
2% Overvalued
57 / 100
76 / 100
$40.7B
Samsung Biologics Co Ltd
KRX:207940
Loading...
1% Overvalued
57 / 100
87 / 100
$31.5B
Mettler-Toledo International Inc
NYSE:MTD
Loading...
27% Overvalued
50 / 100
65 / 100
$30.3B
Sartorius Stedim Biotech SA
PAR:DIM
Loading...
8% Overvalued
47 / 100
48 / 100
$24.3B
Waters Corp
NYSE:WAT
Loading...
19% Overvalued
62 / 100
65 / 100
$23.4B
Illumina Inc
NASDAQ:ILMN
Loading...
7% Overvalued
52 / 100
57 / 100
$21.9B
WuXi Biologics (Cayman) Inc
HKEX:2269
Loading...
14% Undervalued
53 / 100
96 / 100
$20.8B
West Pharmaceutical Services Inc
NYSE:WST
Loading...
12% Overvalued
55 / 100
94 / 100
$19.1B
Divi's Laboratories Ltd
NSE:DIVISLAB
Loading...
35% Overvalued
57 / 100
99 / 100
$18.3B
Medpace Holdings Inc
NASDAQ:MEDP
Loading...
37% Overvalued
71 / 100
76 / 100
$17.5B
Eurofins Scientific SE
PAR:ERF
Loading...
23% Undervalued
50 / 100
50 / 100
$14.9B
ICON PLC
NASDAQ:ICLR
Loading...
34% Undervalued
49 / 100
46 / 100
$14B
R
Revvity Inc
NYSE:RVTY
Loading...
5% Undervalued
48 / 100
50 / 100
$12.9B
T
Tempus AI Inc
NASDAQ:TEM
Loading...
30% Overvalued
33 / 100
46 / 100
$12.5B
Charles River Laboratories International Inc
NYSE:CRL
Loading...
3% Undervalued
50 / 100
41 / 100
$11.1B
Load More